|
Oct 5
|
IQVIA (IQV) and argenx Partner to Advance Autoimmune Care
|
|
Sep 21
|
argenx Announces VYVGART (efgartigimod alfa) Authorized for Sale by Health Canada for Generalized Myasthenia Gravis
|
|
Sep 17
|
New S&P 500 Entrant Airbnb And DKNG Lead 5 Stocks Near Buy Points
|
|
Sep 15
|
How IBD Stock Of The Day Argenx, A Top-Notch Biotech, Is Dominating — With One Drug
|
|
Sep 15
|
argenx Announces Positive CHMP Opinion for Subcutaneous Efgartigimod for Generalized Myasthenia Gravis
|
|
Aug 9
|
Halozyme (HALO) Q2 Earnings & Revenues Beat, 2023 View Raised
|